Pola Orbis Holdings Inc. (TYO:4927)
1,288.50
+13.50 (1.06%)
May 29, 2026, 3:30 PM JST
Pola Orbis Holdings Revenue
Pola Orbis Holdings had revenue of 40.83B JPY in the quarter ending March 31, 2026, a decrease of -1.17%. This brings the company's revenue in the last twelve months to 169.80B, down -0.58% year-over-year. In the year 2025, Pola Orbis Holdings had annual revenue of 170.29B, down -0.04%.
Revenue (ttm)
169.80B
Revenue Growth
-0.58%
P/S Ratio
1.66
Revenue / Employee
43.56M
Employees
3,898
Market Cap
282.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 170.29B | -74.00M | -0.04% |
| Dec 31, 2024 | 170.36B | -2.95B | -1.70% |
| Dec 31, 2023 | 173.30B | 7.00B | 4.21% |
| Dec 31, 2022 | 166.31B | -12.34B | -6.90% |
| Dec 31, 2021 | 178.64B | 2.33B | 1.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paltac | 1.24T |
| Shiseido Company | 973.71B |
| Lion Corporation | 427.06B |
| Rohto Pharmaceutical | 343.73B |
| KOSE Holdings | 329.46B |
| Earth | 182.31B |
| Kobayashi Pharmaceutical | 166.80B |
| MTG Co., Ltd. | 118.64B |